AR-News: Tranzyme to Study Primate Models of Human Disease with SNBL

[סמדר]

From: primfocus at waste.org

http://www.localtechwire.com/article.cfm?u=7803

Tranzyme to Study Primate Models of Human Disease with
SNBL 
Special To LTW 
 
RESEARCH TRIANGLE PARK ・Tranzyme Pharma has
entered a joint research collaboration with Shin
Nippon Biomedical Laboratories (SNBL), Japan's largest
CRO, to develop non-human primate models of human
diseases for medical research and drug discovery. 

Under the terms of the deal, Tranzyme will provide
SNBL access to its functional biology and gene
delivery technology (TExT). SNBL will apply the
technology to ex vivo and in vivo applications using
cells and tissues from non-human primates. 

SNBL will provide research support for the
collaboration and will have an option to license
Tranzyme's technology for commercial purposes.
Additional financial terms of the collaboration were
not disclosed. 

Established in 1957, SNBL has an international
presence with state-of-the-art facilities in Japan,
U.S., Europe and China. In June 2003, SNBL made a
strategic equity investment in Tranzyme. 

"We are pleased to continue to grow our relationship
with SNBL," said Vipin Garg, president and CEO of
Tranzyme. "This collaboration is expected to provide
models of human diseases that are otherwise not
available, resulting ultimately in the discovery of
new pharmaceuticals. Furthermore, these unique animal
models will provide enhanced efficiency for ongoing
drug discovery efforts."

Tranzyme: www.tranzyme.com  
 
Posted: 04/15/2004 09:55 AM






__________________________________
Do you Yahoo!?
Yahoo! Tax Center - File online by April 15th
http://taxes.yahoo.com/filing.html


the wild, cruel beast is not behind the bars of the cage. he is in front of it - axel munthe

"Never doubt that a small group of dedicated citizens can change the world. 
Indeed, it's the only thing that ever has."      Margaret Mead
-------------- next part --------------
An HTML attachment was scrubbed...
URL: http://lists.envirolink.org/pipermail/ar-news/attachments/20040416/458e9b88/attachment.html